NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

Department of Health and Human Services · National Institutes of Health · SBIR Topic · PA-27-101

posted 18 June 2025 · closes 5 April 2029

Summary

The notice announces a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough award for eligible U.S. small businesses that have previously received an NIH SBIR or STTR Phase II award. The description provides eligibility criteria but does not specify any particular technology, system, or advanced capability to be purchased.

View the official notice ↗

Want to know why the government is buying what they buy? Subscribe to the OODA Daily Pulse

The OODA Daily Pulse Report provides a detailed summary of the top technology, cybersecurity and global risks of the day. Our analysts curate stories, articles and insights from hundreds of vetted sources to inform your decisions and our research team provides long form context on topics destined to be of importance. Delivered free to your inbox five days a week at 10:00am.